Related Experiment Video
Updated: Jul 14, 2026
09:33
An Acute Retinal Model for Evaluating Blood Retinal Barrier Breach and Potential Drugs for Treatment
Published on: September 13, 2016
New concepts in bilirubin encephalopathy.
J D Ostrow1, L Pascolo, S M Shapiro
1Department of Medicine, University of Washington School of Medicine, Seattle, WA 98108, USA. jdostrow@medicine.washington.edu
European Journal of Clinical Investigation
|November 26, 2003
Summary
New research on bilirubin encephalopathy reveals that unbound bilirubin (Bf) causes neurotoxicity by damaging brain cells. Early detection of reversible toxicity is now possible, improving treatment strategies for this condition.
Area of Science:
- Neuroscience
- Toxicology
- Biochemistry
Background:
- Bilirubin encephalopathy concepts are evolving based on new toxicity studies.
- Unconjugated bilirubin's unbound fraction (Bf) is key to its neurotoxicity.
- Previously underestimated Bf values due to albumin binding are now corrected.
Purpose of the Study:
- To revise understanding of bilirubin encephalopathy mechanisms.
- To explore the role of unbound bilirubin (Bf) in neurotoxicity.
- To identify new strategies for predicting, preventing, and treating bilirubin encephalopathy.
Main Methods:
- Studies using cultured CNS cells.
- Experiments with congenitally jaundiced Gunn rats.
- Analysis of newer diagnostic tests for reversible neurotoxicity.
Main Results:
- Bf, particularly the protonated diacid, passively crosses cell membranes.
- Early toxicity affects astrocytes and neurons, causing mitochondrial damage and apoptosis.
- Active export via ABC transporters and intracellular mechanisms limit CNS bilirubin.
Conclusions:
- Revised concepts explain varied neonate susceptibility and lesion distribution.
- New diagnostic tests allow detection of reversible neurotoxicity.
- These findings offer improved strategies for managing bilirubin encephalopathy.
Related Concept Videos
01:26Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:19Encephalitis l: Introduction
Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
01:26Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
01:29Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
01:25Jaundice
Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...